NSF Just Restarted SBIR/STTR With \$250 Million, a July 27 Proposal Deadline, a New \$40M Instrumentation Lane, and a Strategic Breakthrough Escalator That Tops Out at \$30 Million Per Company. Here Is How the Restart Changes the Deep-Tech Funding Map.

On May 31, 2026, the National Science Foundation announced the restart of its Small Business Innovation Research and Small Business Technology Transfer programs after a multi-month pause that had left the most active deep-tech non-dilutive funding line in the federal portfolio without an active solicitation. The restart comes with a $250 million FY26 allocation, a reopened Project Pitch portal on June 2, a first full-proposal deadline of July 27, 2026, and an unusually generous award structure: Phase I awards up to $305,000, Phase II up to $1,250,000, Fast-Track combined awards up to $1,555,000, and a new Strategic Breakthrough lane that takes invited Phase II companies up to $30,000,000 in additional funding for high-potential national-security and commercial-deployment-stage work. A separate $40 million pilot solicitation, NSF 26-511, funds next-generation scientific instrumentation and experimental platforms — a category NSF explicitly notes is structurally underserved by venture capital.

The restart matters less for the dollar amount than for the program design choices NSF made under it. The Strategic Breakthrough escalator changes the implied return profile for NSF-funded deep-tech companies. The instrumentation pilot creates a non-dilutive lane for a class of company that has had nowhere to go since the federal instrumentation programs were consolidated in 2018. The deadline cadence — July 27, then November 4, then March 4, 2027, then the first Wednesday in November and first Thursday in March in each subsequent year — locks in a predictable two-window-per-year rhythm that founders can plan capital strategy around. And the Project Pitch gate, which is now an absolute prerequisite for a Phase I proposal, reshapes what early-stage NSF SBIR positioning looks like.

The Granted News brief on the restart is at Granted News. This piece is the deep analysis: program structure, eligibility, what changed, and how to position for July 27.

The Restart in Context: What the Pause Cost the Pipeline

NSF SBIR/STTR has historically been one of the most leveraged non-dilutive funding lines in U.S. deep tech. The agency's own ten-year retrospective covers FY 2016 through FY 2025 and reports more than $2 billion invested in over 1,600 companies, which subsequently raised approximately $36 billion in private capital and produced roughly 380 exits. Run through standard portfolio math, that is an 18:1 ratio of private capital attracted to public dollars deployed — a leverage profile that puts NSF SBIR/STTR ahead of essentially every other federal early-stage R&D vehicle on a per-dollar basis. The combination of patient evaluation cycles, the project-pitch screening gate, the program-director continuity NSF maintains relative to defense SBIR agencies, and the technical-merit-first review culture has historically produced a portfolio of companies that subsequent venture investors find easy to underwrite.

The pause broke that flow. Companies that had been preparing Phase I proposals for the prior cycle's November and March deadlines had nowhere to submit. Companies that had Phase I awards in the pipeline and were planning Phase II proposals saw their commercialization timelines slip. Companies that had been counting on the Phase II-to-Strategic-Outcomes path that NSF had been piloting before the pause lost a key fundraising milestone. Venture investors that use SBIR Phase II awards as a derisking signal for Series A pricing — a common pattern in quantum, biotech tooling, and advanced materials — saw deal velocity drop in the categories most dependent on the NSF signal.

The $250 million restart does not by itself recover the pipeline. It does establish the baseline: a near-doubling of historical FY allocation against the prior decade's run rate, a clear July 27 deadline, and a structure that companies and investors can plan around. The first cycle will be heavily oversubscribed — companies that had been waiting through the pause will flood the July 27 window. Subsequent cycles will normalize as the pipeline rebuilds.

Award Structure: Phase I, Phase II, Fast-Track, Strategic Breakthrough

The four award structures under the restart cover a wider range of company stages than the prior NSF SBIR/STTR portfolio.

Phase I awards run up to $305,000 for six to eighteen months. The Phase I purpose is technical and commercial feasibility — proof of concept work, prototype development, market validation, and team formation. The award size and duration favor companies that are between formation and Series Seed. Companies should expect to spend the Phase I award on a single, focused technical demonstration with a clearly articulated commercial transition plan.

Phase II awards run up to $1,250,000 for approximately twenty-four months. Phase II is for companies that have completed Phase I, demonstrated technical feasibility, and are ready to scale the prototype toward a market-ready product. Phase II proposals require detailed commercialization plans and are evaluated heavily on the strength of the commercial transition narrative. Companies should not assume that a strong Phase I award guarantees a Phase II — the historical Phase I-to-Phase II conversion rate in NSF SBIR sits below 50 percent in most years, and the restart cycle is likely to see additional scrutiny on commercialization plans.

Fast-Track awards combine Phase I and Phase II into a single proposal, up to $1,555,000 total. Fast-Track is appropriate for companies that already have substantial technical and commercial validation entering the proposal and that can credibly argue the Phase I work would be a one-step bridge to Phase II execution. Fast-Track is harder to win than separate Phase I and Phase II proposals because the evaluation panel is essentially asking whether the company is ready to skip the Phase I derisking gate. Companies pursuing Fast-Track should have prior customer engagement, prior technical demonstrations, and a clearly articulated reason that the standard two-step path would lose time without adding value.

Strategic Breakthrough awards are the new structural addition and run up to $30,000,000 per company, by invitation only, to select Phase II companies pursuing technologies of strategic national security and commercial value. The escalator changes the implied total funding from NSF SBIR/STTR from roughly $1.6 million across the standard Phase I + Phase II path to up to $31.6 million across the full path, an order-of-magnitude shift for invited companies. The award is not broadly available — invitation criteria will favor companies with demonstrated commercial traction, clear national security or critical-technology relevance, and an existing investor and customer base that can absorb the Strategic Breakthrough work into a credible commercialization trajectory. For companies in quantum hardware, advanced materials, AI infrastructure, biotechnology tooling, and advanced manufacturing, the Strategic Breakthrough lane is a non-dilutive growth-stage instrument with no real prior analog at NSF.

The Strategic Breakthrough lane connects directly to the equivalent breakthrough escalators that have appeared in the Department of War SBIR/STTR portfolio under Public Law 119-83 (deep dive here). The federal small-business R&D portfolio is converging toward a structure that supports very large non-dilutive growth-stage commitments for select Phase II companies — a structural answer to the dilution pressure that has historically pushed strategically important deep-tech companies into venture capital cycles incompatible with their technology timelines.

The $40 Million Instrumentation Pilot

The separate instrumentation pilot, NSF 26-511, allocates $40 million to companies developing next-generation scientific instrumentation and experimental platforms. Target areas include mass spectrometers, cryo-EM accessories, microfluidic platforms, and quantum sensing hardware. The pilot exists because, in the NSF assistant director's words, "traditional venture capital may not be incentivized to support next-generation scientific instrumentation."

The economic intuition is correct. Scientific instrumentation has long technology cycles, narrow end markets, high development costs, and exit profiles that do not fit venture-scale returns expectations. The companies that have historically commercialized core scientific tools — the cryo-EM accessory vendors, the mass spec consumables companies, the microfluidics platform providers — have typically grown through customer-funded development, NIH research instrumentation grants, and strategic acquisition by larger instrumentation companies. The venture model rarely fits.

The $40 million pilot creates a non-dilutive lane for a class of company that has been structurally underfunded by the U.S. R&D system since the federal instrumentation programs were consolidated under broader SBIR vehicles in 2018. Companies in mass spectrometry, cryo-electron microscopy accessories, microfluidic platforms, quantum sensing hardware, and analogous categories should treat NSF 26-511 as a first-class funding line rather than a secondary option to the general SBIR solicitation.

Eligibility under the instrumentation pilot tracks the general SBIR eligibility — 500 or fewer employees including affiliates, PI employment at minimum 51 percent with the small business, PI work authorization in the U.S., and the standard submission limits. Project Pitch submissions for the instrumentation pilot route through the same portal as the general SBIR solicitation, but proposals should be explicit about the instrumentation framing.

The Project Pitch Gate: Why It Reshapes Early-Stage Positioning

NSF SBIR/STTR is the only major federal small-business R&D program with a mandatory pre-proposal screening step. The Project Pitch is a three-page summary of the technical innovation, the market opportunity, the company team, and the technical approach. NSF program directors review pitches and issue invitations for full Phase I proposals only to companies that pass the screen. Companies that submit Phase I proposals without an invitation are returned without review.

The Project Pitch gate reshapes early-stage positioning in two ways. First, it shortens the cycle for companies that would not have made it through full proposal review. A company that does not have a clear technical innovation, a defensible market opportunity, or a credible team will get a no-go on the pitch in a matter of weeks rather than waiting through a multi-month full proposal review. Second, it creates an asymmetric signal for companies that pass the pitch. An invitation to submit a Phase I proposal is itself a partial endorsement from NSF — a signal that investors, customers, and downstream partners can read.

The submission limits matter. Entrepreneurs may submit up to two pitches annually, with a three-submission cap per technology. The cap is enforceable across cycles and across companies that share a founder, so companies should not assume they can keep iterating on the same pitch indefinitely. Companies should treat the first pitch submission as a meaningful commitment and should invest the time to ensure the technical framing, the market framing, and the team narrative are tight before submitting.

The Project Pitch portal reopened June 2, 2026. Companies targeting the July 27 full-proposal deadline need an invitation from a pitch submitted in the early weeks of the reopened window — pitches submitted in late June or early July will not return invitations in time for the July 27 cycle. Companies that miss the July 27 window can target November 4, then March 4, 2027, then the steady-state first-Wednesday-in-November and first-Thursday-in-March cadence.

Eligibility: What the 500-Employee Rule, the 51 Percent PI Rule, and the Work-Authorization Rule Actually Mean

The eligibility rules are tighter than many founders realize and have historically been the source of the most common disqualifications.

The 500-employee cap is measured including affiliates. Companies that have raised venture capital from large funds need to look carefully at whether any of their portfolio-mate companies, or the fund's other portfolio companies under common control, push the affiliate count above 500. The Small Business Administration's affiliate rules are complex and have caught companies that thought they were safely under the cap.

The 51 percent PI employment rule requires the Principal Investigator to be employed by the small business at a minimum of 51 percent through the project period. This rule disqualifies the common arrangement where a university faculty member serves as the technical lead on a small-business proposal while remaining a full-time faculty member. The PI must actually be a primary employee of the company. The rule does not disqualify university partnerships — companies can subaward to university labs and bring in faculty as co-PIs — but the named Principal Investigator on the NSF proposal must be a company employee.

The PI work authorization rule requires the Principal Investigator to have legal authority to work in the United States. The rule is enforced and applies to the PI specifically, not to the broader team. Companies founded by recent-arrival immigrant scientists need to confirm work authorization status for the PI before submitting a pitch.

The PI effort rule requires a minimum of one calendar month of effort per six-month performance period. The rule is light by federal grant standards and is rarely a binding constraint.

The submission limit rule allows one proposal per organization and PI under consideration at NSF simultaneously. Companies cannot stack pitches across topics to increase their odds — the cap is real.

Positioning for July 27

The July 27 deadline favors companies that already have a clear technical innovation, a defensible market opportunity, and a credible team narrative. Companies that meet those bars should plan a four-step path to July 27: submit the Project Pitch by mid-June to allow review time, prepare the Phase I or Fast-Track proposal in parallel during the pitch review window, target invitation receipt in early July, and submit the full proposal with two weeks of buffer ahead of the deadline.

Companies that do not yet have the technical and market clarity to submit a strong pitch should target the November 4 cycle. The November cycle will be less oversubscribed than July — the post-restart pipeline will have flowed through — and will give companies the time to refine the pitch before submission. The cost of waiting one cycle is small relative to the cost of submitting a weak pitch and burning one of the two annual pitch attempts.

Companies in instrumentation categories should plan a parallel track on NSF 26-511. The instrumentation pilot has its own evaluation criteria and will likely have less competition than the general solicitation in its first cycle. The pilot is a four-year vehicle as currently designed and offers a credible non-dilutive path for companies that would otherwise struggle in the venture market.

For companies in the Strategic Breakthrough-eligible categories — quantum hardware, advanced AI infrastructure, biotechnology tooling, advanced materials, advanced manufacturing — the long-term strategic value of the restart is the escalator lane. The path to a Strategic Breakthrough invitation runs through Phase II performance, demonstrated commercial traction, and clear national-security or critical-technology relevance. Companies pursuing Phase I or Phase II should design proposals with the escalator in mind, even though invitation criteria will not be published in advance.

What to Watch

Three things to watch over the next twelve months. First, whether the July 27 cycle attracts the post-pause backlog as expected and whether NSF's review capacity keeps pace with submission volume. Second, whether the first Strategic Breakthrough invitations get issued, to whom, and on what criteria — the answers will reshape the deep-tech non-dilutive funding map. Third, whether the $40 million instrumentation pilot gets renewed and expanded beyond the FY26 commitment, which will determine whether the U.S. scientific instrumentation sector has a structural non-dilutive path going forward.

The restart is a real change to the deep-tech funding landscape. Companies that fit the program should treat the July 27 deadline as the first window in a multi-cycle commitment and should plan their non-dilutive fundraising strategy around the predictable NSF cadence. The Project Pitch portal is open. The clock is running.